医学
四分位间距
癌症
内科学
抗体
效价
接种疫苗
抗体效价
前瞻性队列研究
单变量分析
队列
免疫学
多元分析
作者
Amir Massarweh,Noa Eliakim‐Raz,Amos Stemmer,Adva Levy‐Barda,Shlomit Yust‐Katz,Alona Zer,Alexandra Benouaich‐Amiel,Haim Ben‐Zvi,Neta Moskovits,Baruch Brenner,Jihad Bishara,Dafna Yahav,Boaz Tadmor,Tal Zaks,Salomon M. Stemmer
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2021-05-28
卷期号：7 (8): 1133-1133
被引量：277
标识
DOI：10.1001/jamaoncol.2021.2155
摘要
Patients with cancer undergoing treatment are at high risk of COVID-19 following SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to messenger RNA SARS-CoV-2 vaccines is unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
CAOHOU
yx_cheng
Nico
乐乐乐乐乐乐
eric888
勤劳的猕猴桃
代芙
23
YifanWang
aldehyde
lanxinyue
核桃
COSMAO
大家一起发发发
FIN
MchemG
yyds
54Darren
仁爱的大白
科目三
皖公网安备34019202002308
